Brown Advisory’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,648
Closed -$47.5K 1260
2023
Q1
$47.5K Hold
8,648
﹤0.01% 1189
2022
Q4
$43.1K Hold
8,648
﹤0.01% 1187
2022
Q3
$48K Hold
8,648
﹤0.01% 1112
2022
Q2
$76K Buy
8,648
+533
+7% +$5.41K ﹤0.01% 1080
2022
Q1
$127K Hold
8,115
﹤0.01% 1079
2021
Q4
$215K Buy
8,115
+1,803
+29% +$68.4K ﹤0.01% 1152
2021
Q3
$308K Buy
6,312
+1,654
+36% +$102K ﹤0.01% 934
2021
Q2
$393K Hold
4,658
﹤0.01% 887
2021
Q1
$472K Hold
4,658
﹤0.01% 858
2020
Q4
$469K Buy
4,658
+904
+24% +$60.4K ﹤0.01% 792
2020
Q3
$174K Buy
3,754
+1,541
+70% +$79.1K ﹤0.01% 915
2020
Q2
$127K Buy
+2,213
New +$148K ﹤0.01% 916

Other funds holding AWH

Brown Advisory's AWH Position: Q2 2023 in Review

Brown Advisory sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2023, closing a stake of 8,648 shares — an estimated $47.5K sold.

Brown Advisory first reported a position in AWH in Q2 2020 and held it in 12 quarters. The position peaked at $472K in Q1 2021. 22 funds tracked by Wall St. Rank hold AWH as of Q2 2023.

  • Brown Advisory reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Brown Advisory sold 8,648 Aspira Women's Health Inc. Common Stock shares in Q2 2023, an estimated $47.5K.
  • Brown Advisory first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • Brown Advisory's Aspira Women's Health Inc. Common Stock position peaked at $472K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2023.

Based on Brown Advisory's 13F filing for Q2 2023, filed 31 Jul 2023.